| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 10/03/2006 | US7115642 Inhibits replication and/or proliferation of Hepatitis C virus (HCV) |
| 10/03/2006 | US7115639 useful in the treatment and/or prevention of preterm labor, premature birth and dysmenorrhea; in particular, the present invention is related to pyrrolidine derivatives displaying a substantial modulatory, notably an antagonist activity of the oxytocin receptor |
| 10/03/2006 | US7115636 use as antiviral agents; treatment of cytomegalovirus infection |
| 10/03/2006 | US7115635 Benzylpiperidine compound |
| 10/03/2006 | US7115630 Metabotropic glutamate receptor antagonists |
| 10/03/2006 | US7115627 Trypsin-like serine protease enzyme inhibitors; anticoagulants |
| 10/03/2006 | US7115617 Anticarcinogenic and kinase inhibitor; a heteroaryl(containing atleast one oxygen or sulfur atom)amino substituted pyrimidine compound |
| 10/03/2006 | US7115615 Antitumour agents as enzyme inhibitors of the nonreceptor tyrosine protein kinases involved in the signal transduction; noninvasive; antimetatic and -carcinogenic agents; derivatives of 4-(1,3-benzo-dioxol-4-yl)amino-)quinazoline |
| 10/03/2006 | US7115612 Arylsulfonamides as antiviral agents |
| 10/03/2006 | US7115608 Pyridinone and pyridinethione derivatives having HIV inhibiting properties |
| 10/03/2006 | US7115607 Substituted piperazinyl amides and methods of use |
| 10/03/2006 | US7115601 spirocycle-substituted pyrimidinecarboxamides such as N-[(4-fluorophenyl)methyl]-1,6-dihydro-5-hydroxy-1-methyl-6-oxo-2-(1,4,9-triazaspiro[5.5]undec-9-yl)-4-pyrimidinecarboxamide for treating HIV infection and AIDS |
| 10/03/2006 | US7115597 Tyrosine kinase inhibitors |
| 10/03/2006 | US7115596 Thiazole compounds as integrin receptor antagonists derivatives |
| 10/03/2006 | US7115545 5-Phenylcarbonyloxy-1-methyl-1H-pyrazol-4-yl)-(8-methyl-sulfonyl-3a,4-dihydro-3H-indeno[1,2-c]isoxazol-5-yl)methanone |
| 10/03/2006 | CA2247946C Anticachectic composition |
| 10/03/2006 | CA2187130C Novel sulphonamides |
| 09/28/2006 | WO2006101860A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 09/28/2006 | WO2006101245A1 N-substituted-n-(4-piperidinyl) amide derivative |
| 09/28/2006 | WO2006100633A1 NOVEL THIOPHENE DERIVATIVES AS SPHINGOSINE-l-PHOSPHATE-1 RECEPTOR AGONISTS |
| 09/28/2006 | WO2006100631A1 Hydrogenated benzo (c) thiophene derivatives as immunomodulators |
| 09/28/2006 | WO2006100181A2 New salt and polymorphs of a dpp-iv inhibitor |
| 09/28/2006 | WO2006100036A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/28/2006 | WO2006100009A1 Cgrp antagonists, method for the production thereof, and their use as medicaments |
| 09/28/2006 | WO2006099884A1 Beta-aminoalcohol antibiotics |
| 09/28/2006 | WO2006099735A1 Thiadiazole substituted coumarin derivatives and their use as leukotriene biosynthesis inhibitor |
| 09/28/2006 | WO2006078992A3 Heteroaryl substituted piperazinyl-pyridine analogues |
| 09/28/2006 | WO2006053342A3 Integrin antagonists useful as anticancer agents |
| 09/28/2006 | WO2006025979A3 Modulators of nuclear receptors |
| 09/28/2006 | WO2005080384A3 Benzimidazole derivative and use as aii receptor antagonist |
| 09/28/2006 | WO2005040157A3 Novel mch receptor antagonists |
| 09/28/2006 | WO2005013914A8 Heteroarylaminosulfonylphenyl derivatives for use as sodium or calcium channel blockers in the treatment of pain |
| 09/28/2006 | WO2004070352A3 Methods, mixtures, kits and compositions pertaining to analyte determination |
| 09/28/2006 | US20060217559 Miticidal triazolidine derivatives |
| 09/28/2006 | US20060217433 Sulfonamide derivatives as ppar modulators |
| 09/28/2006 | US20060217428 Salt and polymorphs of a DPPIV inhibitor |
| 09/28/2006 | US20060217427 Cytoskeletal active compounds, compositions and use |
| 09/28/2006 | US20060217418 Antagonists for melanin concentrating hormone-1 receptors; antidepressants, anxiolytic agents; incontinence, obesity |
| 09/28/2006 | US20060217399 Phenyl quinolines and their use as estrogenic agents |
| 09/28/2006 | US20060217379 1,2,3-Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto such as diabetes and hyperglycemia |
| 09/28/2006 | US20060217377 Quinazolines useful as modulators of ion channels |
| 09/28/2006 | US20060217376 Therapeutic pyrazolo[3,4-b]pyridines and indazoles |
| 09/28/2006 | US20060217374 {6-[5-Methyl-2-(4-trifluoromethyl-phenyl)-oxazol-4-ylmethoxy]-benzo[b]thiophen-3-yl}-acetic acid; antidiabetic agent; metabolic Syndrome, hyperglycemia, hyperlipidemia, obesity, coagaulopathy, hypertension, atherosclerosis; lowering fibrinogen, increasing HDL levels |
| 09/28/2006 | US20060217372 Diaryl ethers as opioid receptor antagonist |
| 09/28/2006 | US20060217364 Beta-lactamyl vasopressin V1a antagonists |
| 09/28/2006 | CA2602475A1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 09/28/2006 | CA2602474A1 Hydrogenated benzo (c) thiophene derivatives as immunomodulators |
| 09/28/2006 | CA2601523A1 Novel thiophene sulfoximines for treating complement-mediated diseases and conditions |
| 09/28/2006 | CA2600909A1 Cgrp antagonists, method for the production thereof, and their use as medicaments |
| 09/28/2006 | CA2600063A1 3, 4-substituted pyrrolidine derivatives for the treatment of hypertension |
| 09/27/2006 | EP1705179A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 09/27/2006 | EP1704145A1 Selective kinase inhibitors |
| 09/27/2006 | EP1703906A1 Immuno inhibitory pyrazolone compounds |
| 09/27/2006 | EP1703905A1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 09/27/2006 | EP1703797A2 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 09/27/2006 | EP1594840B1 Piperidine-benzenesulfonamide derivatives |
| 09/27/2006 | EP1501826B1 Substituted indoles as alpha-1 agonists |
| 09/27/2006 | EP1421078B1 Indole derivatives as beta-3 adrenergic agonists for the treatment of type 2 diabetes |
| 09/27/2006 | EP1383757B1 Antagonists of mcp-1 function and methods of use thereof |
| 09/27/2006 | CN1839128A Mitotic kinesin inhibitors |
| 09/27/2006 | CN1276919C Preparation method of azithromycin and crystal 9-deoxidation-9a-aza-9a-homoilotycin A hydrate used therein |
| 09/26/2006 | USRE39308 3,5-dioxa-12-azawurtzitane compound and process of preparing same |
| 09/26/2006 | US7112680 Condensing a heterocyclic ketone or aldehyde with a 2-(NH2-NH-)benzimidazole, -oxazole or -thiazole; ribonucleotide reductase inhibitors; anticarcinogenic and -tumor agents; also useful against multidrug resistant cells |
| 09/26/2006 | US7112600 A therapeutic agent for treating hepatitis C, based on polymerase inhibitory activity |
| 09/26/2006 | US7112599 Oxazole compounds for the treatment of neurodegenerative disorders |
| 09/26/2006 | US7112597 5-(Substituted thiazolylethoxy)indaneacetic acid derivatives, used in the treatment of diseases such as diabetes, obesity, hyperlipidemia, and atherosclerotic diseases |
| 09/26/2006 | US7112595 Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists |
| 09/26/2006 | US7112587 e.g., N-Cycloheptyl-N'(1-ethyl-pyrrolidin-2-ylmethyl)-6-(3-fluoro-4-methoxy-phenoxy)-[1,3,5]triazine-2,4-diamine; treating unwanted cellular proliferation, an inflammation mediated disease, or a hyperproliferative disease, or modulating a glycosidase enzyme |
| 09/26/2006 | US7112584 Antiinflammatory agents; antiarthritic agents; antiallergens; antiinflammatory agents |
| 09/26/2006 | CA2536501C Crystal forms of azithromycin |
| 09/21/2006 | WO2006099060A2 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006098982A1 Process for the preparation of opioid modulators |
| 09/21/2006 | WO2006098684A1 Novel compounds ii 2-pyridine derivatives as inhibitors of neutrophile elastase. |
| 09/21/2006 | WO2006098683A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 09/21/2006 | WO2006098489A1 Compound, composition, retardation plate, elliptically-polarizing plate and liquid-crystal display device |
| 09/21/2006 | WO2006097808A1 Benzimidazolone derivatives as cb2 receptor ligands |
| 09/21/2006 | WO2006097474A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | WO2006097460A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | WO2006097261A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |
| 09/21/2006 | WO2006097175A1 Dpp-iv inhibitors |
| 09/21/2006 | WO2006097030A1 Bisheterocycle tandem compounds useful as antiviral agents, the uses thereof and the compositions comprising such compounds |
| 09/21/2006 | WO2006060712A3 Potassium salt of an hiv integrase inhibitor |
| 09/21/2006 | WO2006002421A3 Modulators of atp-binding cassette transporters |
| 09/21/2006 | US20060211861 Process for the preparation of opioid modulators |
| 09/21/2006 | US20060211751 Zolmitriptan crystal forms |
| 09/21/2006 | US20060211750 Triazole derivatives |
| 09/21/2006 | US20060211735 4-Arylsulphonylpiperidine derivatives for antagonism of the 5-ht2a receptor |
| 09/21/2006 | US20060211728 Thalidomide analogs |
| 09/21/2006 | US20060211694 antiinflammatory agent for treating asthma and chronic pulmonary inflammatory disease |
| 09/21/2006 | US20060211693 Cis-imidazolines |
| 09/21/2006 | US20060211692 reacting cis-hydroxy-D-proline with 4-chlorophenyl iso-cyanate forming intermediate 1(4-chlorophenylcarbamoyl)-4-hydroxypyrrolidine-2-carboxylic acid, reacting intermediate with aminophenylmorpholinone; 1-[(4-chlorophenyl)]-2-{[4-(3-oxomorpholin-4-yl)phenyl]}-(2R)-pyrrolidine-1,2-dicarboxamide |
| 09/21/2006 | US20060211689 Aminoquinoline derivatives and their use as adenosine A3 ligands |
| 09/21/2006 | US20060211656 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators |
| 09/21/2006 | CA2602173A1 Dpp-iv inhibitors |
| 09/21/2006 | CA2601674A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2601481A1 Process for the preparation of opioid modulators |
| 09/21/2006 | CA2600528A1 Hydroxamates as histone deacetylase inhibitors and pharmaceutical formulations containing them |
| 09/21/2006 | CA2600038A1 2-pyridine derivatives as inhibitors of neutrophile elastase |
| 09/21/2006 | CA2599538A1 N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 09/21/2006 | CA2599476A1 Cis-2,4,5-triaryl-imidazolines and their use as anti-cancer medicaments |